Regulation

Congress Urged to Protect Medicare and Medicaid Funding
Public Policy Congress Urged to Protect Medicare and Medicaid Funding

Today, we're privileged to have Faisal Zain, a pioneering healthcare expert renowned for his contributions to the field of medical technology and manufacturing of diagnostic devices. With his extensive experience, Mr. Zain has been at the forefront of innovation, driving progress in medical

AI Revolutionizes Oncology: Rakovina's Cutting-Edge Strategies
Care AI Revolutionizes Oncology: Rakovina's Cutting-Edge Strategies

In recent years, the integration of artificial intelligence in oncology has been nothing short of revolutionary, fundamentally altering the landscape of cancer treatment and diagnosis. AI has carved a path for enhanced precision in medicine, offering new methodologies that were previously

How Will NC's PA Reform Impact Healthcare Access?
Care How Will NC's PA Reform Impact Healthcare Access?

In a significant move towards enhancing healthcare delivery, North Carolina has implemented substantial reforms impacting physician assistant (PA) practices. The state’s healthcare industry, marked by a complex landscape, is about to undergo transformative changes driven by House Bill 67. This b

Is Wildfire Smoke the Next Big Public Health Crisis?
Care Is Wildfire Smoke the Next Big Public Health Crisis?

Faisal Zain is a highly respected healthcare expert with a specialized focus on medical technology. His deep involvement in the manufacturing of medical devices has positioned him at the forefront of innovation in diagnostics and treatment. Today, he brings his expertise to a critical topic: the

Can McKay Propel Noridian's Quest for Quality in Healthcare?
Process Can McKay Propel Noridian's Quest for Quality in Healthcare?

Faisal Zain, a distinguished expert in medical technology with a focus on device manufacturing for diagnostics and treatment, has been a driving force in healthcare innovations. As someone deeply involved in transforming medical solutions, Faisal shares insights on quality management and continuous

FDA Approves Lenacapavir: A Twice-Yearly HIV Prevention Breakthrough
Public Policy FDA Approves Lenacapavir: A Twice-Yearly HIV Prevention Breakthrough

Lenacapavir has recently been approved by the FDA as a twice-yearly injection, marking a significant milestone in the efforts toward global HIV prevention. This innovative treatment developed by Gilead Sciences, branded as Yetzugo, promises to revolutionize the landscape of HIV prevention efforts

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later